
· Executive Brief
Healthy Lung Month 2026
Move from recognition activity to a visible operating route with named owners and closed loops.

Leadership signal
Use Healthy Lung Month to examine the system behind the message.
Leaders can use this window to test whether public information, service entry points, internal referrals, and follow-up responsibilities form one understandable route. The review should start with the experience of people using the system and the teams responsible for receiving them.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Lung health is a pathway problem before it is a campaign
Chronic lung disease reaches health systems through many doors at once. They include primary care visits for breathlessness, emergency department surges on poor air days, inpatient stays for exacerbations, screening programs for people with long smoking histories, and rehabilitation services that many eligible patients never reach. A modeling study estimated that 10.3% of adults aged 30 to 79 worldwide, about 391.9 million people, met the spirometric definition of COPD in 2019.[9] That scale means lung health cannot be managed as a single service line or a single month of messaging.
The operating risk for executives is not a lack of effective services. It is that each service depends on a prior step that often fails quietly. In 2022, only 18.1% of eligible U.S. adults aged 50 to 79 were up to date with lung cancer screening.[3] After a COPD hospitalization, only 1.5% of Medicare beneficiaries in a national cohort started pulmonary rehabilitation within 90 days, even though early initiation was associated with lower one-year mortality.[14]
These gaps sit between departments. Diagnosis depends on spirometry being ordered and interpreted, screening depends on orders, scheduling and result follow-up, and recovery after an admission depends on referrals that someone must accept. Healthy Lung Month is a useful moment for leaders to ask where those dependencies break and who is accountable for closing them. The same question applies to policy measures: readmission rates for COPD can improve while post-discharge mortality worsens, so leaders need a balanced view of outcomes rather than a single target.[11]
The sections below summarize current peer-reviewed evidence on burden, diagnosis, screening follow-through, tobacco treatment, environmental exposure, transitions and equity. They are intended to sit beside the executive guidance already on this page, giving boards and operating leaders a shared factual base for deciding where to act first.
Current evidence
What the research says about burden, diagnosis and screening
The burden is large and concentrated where prevention and diagnosis are weakest. In the same global analysis, about 80.5% of COPD cases were in low- and middle-income countries.[9] Current smoking (odds ratio 3.2), biomass exposure (1.4) and occupational dust or smoke exposure (1.4) were each risk factors.[9] Prevalence was highest in the Western Pacific region (11.7%) and lowest in the Americas (6.8%).[9] For U.S. health systems that serve immigrant, rural or industrial communities, those exposure patterns are a reminder that tobacco is not the only risk to screen for.
Diagnosis is unreliable in both directions. A primary care meta-analysis found that 16% of people who smoked, regardless of symptoms, met spirometric criteria for COPD but did not report a COPD-related diagnosis.[6] So did 25% of patients taking inhaled therapies.[6] The same review found that only 50% to 75% of patients with a documented COPD diagnosis had airflow obstruction on post-bronchodilator spirometry.[6] Underdiagnosis delays treatment, while overdiagnosis can expose patients to therapies and costs that do not match their condition.
Lung cancer screening shows a similar gap between eligibility and completion. Screening prevalence in 2022 ranged from 9.7% in Wyoming to 31.0% in Rhode Island, and it was 3.7% among uninsured eligible adults and 5.1% among those without a usual source of care.[3] Staying on schedule is also uneven: a meta-analysis of 15 U.S. studies with 16,863 people reported pooled adherence to repeat screening of 55%, lower among people who currently smoked.[12]
Environmental exposure adds a time-sensitive layer. In a systematic review of five studies from the United States and Canada, all reported more respiratory symptoms, hospital visits and medication use among youth on days with significant wildfire smoke.[2] The authors noted that differences in exposure measurement and outcome definitions limited comparison across studies, so the finding supports preparedness rather than precise forecasting.[2]
Taken together, the evidence points to a consistent pattern: effective diagnostic, screening and rehabilitation services exist, but the share of eligible people who complete them is low and varies by place, insurance and smoking status. That is a system design problem that executives can own. It also means that the most useful local data are completion rates at each step, not counts of outreach activity or scans performed.[3][12]
Figure 1
Lung health services work, but few eligible patients complete them
Percent of eligible or enrolled people completing a pathway step, as reported in each study. Values are copied from the cited studies [3], [4], [12], [14]; none is estimated.
Data note. These values come from different studies, populations, years and definitions of completion, so this is an indirect comparison; the bars show where pathways leak, not how one step compares with another.
Limitation. Each value reflects its own setting and denominator; the rehabilitation figure is from 2014 Medicare data and the screening figures measure different steps of the screening process.
Figure data (4 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Started pulmonary rehabilitation within 90 days of COPD discharge | 1.5% | 2,721 of 197,376 fee-for-service Medicare beneficiaries hospitalized for COPD in 2014 | [14] |
| Completed first three screening steps with navigation | 12% | Navigation arm of a randomized trial in an urban U.S. safety-net health system; 447 patients in total | [4] |
| Up to date with lung cancer screening | 18.1% | Eligible U.S. adults aged 50 to 79, national survey, 2022 | [3] |
| Pooled adherence to repeat lung cancer screening | 55% | Meta-analysis of 15 U.S. studies, 16,863 people, follow-up periods of 12 to 36 months | [12] |
Continuum of care
Where the continuum breaks after diagnosis, admission and screening
The hospitalization for a COPD exacerbation is one of the clearest moments when the continuum either holds or fails. In a cohort of 197,376 Medicare beneficiaries, starting pulmonary rehabilitation within three months of discharge was associated with lower one-year mortality (hazard ratio 0.63; absolute risk difference 6.7 percentage points).[14] Every three additional sessions was associated with lower risk of death.[14] Within one year, 7.3% of early starters died, compared with 19.6% of those who started later or not at all.[14] The authors cautioned that residual confounding is possible, but the finding makes the referral and enrollment step a priority for transition planning.[14]
Structured transitional care offers some support for that work. An updated meta-analysis found a lower relative risk of COPD readmission with transitional care after discharge.[8] Differences in the number of readmissions and emergency visits, however, were not statistically significant.[8] Leaders should read that as evidence that transition programs can help, while recognizing that their design and intensity matter.
Policy incentives have not produced uniformly good results. In 4,587,542 Medicare admissions for COPD, 30-day readmission fell from 20.54% to 18.74% across the study period.[11] Over the same span, 30-day post-discharge mortality rose from 6.91% before the readmissions program was announced to 7.30% during implementation.[11] The authors called for further research to confirm and explain the association, but the result is a caution against managing to a single readmission metric.[11]
Screening has its own continuum. In a safety-net trial, the main reason patients did not complete the first steps of lung cancer screening was that the screening steps were never ordered.[4] A pathway that starts with eligibility, moves through ordering, imaging, result communication and annual return, and links positive findings to diagnostic evaluation needs an accountable owner at each transition, not only at the scan.
Tobacco treatment belongs inside both pathways. An opt-out inpatient program in six hospitals referred every adult who smoked to treatment, showing broad reach.[5] In lung cancer screening, integrating longitudinal cessation care was feasible and associated with clinically meaningful quit rates.[7] In that trial, 19.8% of participants had quit early in treatment, and stepping these early quitters down to quarterly contact was not recommended.[7] Cessation works better as a longitudinal service than a single conversation at the scan.
Figure 3
Why the pathway breaks
People
- Tobacco treatment specialist caseloads too high to deliver bedside consults
- Limited clinician time to explain rehabilitation benefits
- Navigators unable to act when screening steps are not ordered
Process
- Screening steps never ordered after eligibility is identified
- No default referral to pulmonary rehabilitation at discharge
- Cessation medications not prescribed at discharge
Technology
- Ordering workflow for screening steps is complex
- Spirometry not available or not interpreted in primary care
- No shared tracking of annual screening return
Environment
- Wildfire smoke and poor air quality events
- Biomass and occupational dust or smoke exposure
- Distance and transportation to rehabilitation programs
Policy
- Uninsured patients and those without a usual source of care rarely screened
- Readmission incentives that may not track mortality
- Weak linkage to post-discharge cessation services
Measurement
- Completion not tracked beyond the first scan or referral
- Results not stratified by race, insurance or usual source of care
- COPD labels not confirmed by spirometry
Unranked qualitative cause-and-effect diagram for the outcome in the box: Eligible patients do not complete diagnosis, screening follow-up, tobacco treatment or pulmonary rehabilitation after a qualifying event Causes are assembled from the cited literature [1], [2], [3], [4], [5], [6], [9], [10], [11], [14]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Tobacco treatment specialist caseloads too high to deliver bedside consults; Limited clinician time to explain rehabilitation benefits; Navigators unable to act when screening steps are not ordered |
| Process | Screening steps never ordered after eligibility is identified; No default referral to pulmonary rehabilitation at discharge; Cessation medications not prescribed at discharge |
| Technology | Ordering workflow for screening steps is complex; Spirometry not available or not interpreted in primary care; No shared tracking of annual screening return |
| Environment | Wildfire smoke and poor air quality events; Biomass and occupational dust or smoke exposure; Distance and transportation to rehabilitation programs |
| Policy | Uninsured patients and those without a usual source of care rarely screened; Readmission incentives that may not track mortality; Weak linkage to post-discharge cessation services |
| Measurement | Completion not tracked beyond the first scan or referral; Results not stratified by race, insurance or usual source of care; COPD labels not confirmed by spirometry |
Access
Making diagnosis, rehabilitation and tobacco treatment reachable
Access to lung health services depends as much on whether a service is offered by default as on whether it exists. An opt-out program in six South Carolina hospitals automatically referred adult inpatients who smoked to a bedside consult plus follow-up call, or the call alone.[5] Smoking prevalence ranged from 14% to 49%, and 6,000 patients were referred.[5] Of patients eligible for the automated follow-up call, 43% answered it.[5] Six-week quit rates among surveyed patients were 20% to 30% and were similar across hospitals and care groups.[5]
That same program showed where access thins out. Consult delivery was lowest where specialists carried the most referred patients.[5] The authors named staffing ratios, discharge prescribing of cessation medications and linkage to post-discharge services as areas to strengthen.[5] For executives, the lesson is that default enrollment raises reach, but capacity and discharge workflows determine whether reach becomes treatment.
Longitudinal support is harder to sustain than an initial offer. In a randomized trial of tobacco treatment delivered within lung cancer screening, 24.4% of participants reported six-month prolonged abstinence at 18 months.[7] Adding medication therapy management for early nonresponders did not significantly improve abstinence (17.8% versus 16.4%), and only 39% of those assigned to it completed at least one visit.[7] Access, in other words, includes whether patients can and will use the added service.
Pulmonary rehabilitation access remains a persistent gap. A 2026 mixed-method systematic review of 28 studies grouped the factors affecting uptake and completion into patient characteristics and considerations, nurse-related factors, organizational determinants and individual variables.[1] The review concluded that skilled nurses and other clinicians play a key role in encouraging participation and explaining the benefits of rehabilitation.[1] Combined with the low early initiation seen after hospitalization, this points leaders toward organizational determinants they control: referral defaults, scheduling, program capacity and clinician time to explain the service.[14]
Spirometry access is the upstream condition for all of this. When a quarter of patients already taking inhaled therapies meet spirometric criteria for COPD without a reported diagnosis, primary care testing deserves executive attention.[6] Each of these services is easier to reach when it is the default, staffed to demand and connected to the next step, which is a design choice within executive control.[5]
Executive guidance · System route
Connect the month to an accountable system route.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Listen
Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entry
Publish a plain-language first step and identify who receives requests through each approved channel.
Coordinate the partner route
Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal.
Protect transitions
Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learn
Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Listen | Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions. |
| Clarify entry | Publish a plain-language first step and identify who receives requests through each approved channel. |
| Coordinate the partner route | Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal. |
| Protect transitions | Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations. |
| Verify and learn | Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals. |
Equity and trust
Equity gaps appear at every step of the lung health pathway
Disparities in lung health do not stop at eligibility. A meta-analysis found lower adherence to lung cancer screening follow-up among Black patients than White patients, which makes follow-up, not only eligibility, an equity question for executives.[10] The median adherent follow-up rate was 37%, and the racial gap persisted across all malignancy risk levels.[10]
Single-program data show the same pattern earlier in the process. In one academic screening program, Black patients referred for screening were significantly less likely than White patients to receive a low-dose CT scan, even after accounting for individual risk factors and neighborhood-level factors.[13] Black patients also showed a trend toward delayed follow-up and loss to follow-up across result categories, and annual adherence was low for all patients regardless of race.[13]
Coverage and connection to care shape who reaches screening at all. Screening prevalence was 3.7% among uninsured eligible adults and 5.1% among those without a usual source of care, compared with 18.1% overall.[3] The pooled adherence analysis found White patients more likely to adhere to repeat screening than patients of other races (odds ratio 2.0).[12] People with four or more years of college also adhered more often.[12] These differences point to navigation, scheduling, transportation and communication design, not individual motivation alone.
Safety-net settings show that navigation alone is not sufficient. In a randomized trial at an urban safety-net system where 69% of participants were from racial and ethnic minority groups, telephone navigation did not change completion of the first three screening steps (12% versus 9%).[4] Once steps were ordered, completion was higher with navigation (86% versus 79%).[4] The authors recommended pairing navigation with clinical team education and electronic record changes that simplify ordering.[4]
Equity also has an environmental dimension. Exposure to biomass smoke and occupational dust or fumes was associated with COPD in the global analysis, and wildfire smoke was linked to more respiratory symptoms and hospital visits among children and adolescents.[9][2] Communities with these exposures need lung health services that reach them where they live and work. Trust is built when the organization can show, with stratified data, that the people most exposed are also the people who complete diagnosis, screening and rehabilitation.[10][13]
Human infrastructure
The people who make lung health pathways work
Lung health pathways rely on a relatively small number of specialized roles: tobacco treatment specialists, respiratory therapists, pulmonary rehabilitation staff, screening coordinators, navigators and the primary care teams who order and interpret spirometry. When any of these roles is thinly staffed, the effect shows up as missed steps rather than visible failure.
The South Carolina opt-out program illustrates the staffing effect directly. Bedside consult delivery varied across hospitals and was lowest where each tobacco treatment specialist carried the highest volume of referred patients.[5] The authors named staffing ratios among the main areas for improvement.[5] An automatic referral without matching capacity creates a queue rather than a service.
Navigation is valuable, but it depends on the clinical team. In the safety-net screening trial, patients often did not complete screening steps because those steps were never ordered, and navigation helped only once steps were ordered.[4] The trial’s authors pointed to clinician education and simpler ordering in the electronic record as companions to navigation.[4] For executives, the implication is that navigator programs need a defined relationship with ordering clinicians and clear rules for what navigators can initiate.
Nurses and other clinicians shape rehabilitation participation. The 2026 systematic review identified nurse-related factors as one of four themes influencing uptake and completion and concluded that skilled clinicians facilitate participation by encouraging patients and communicating benefits.[1] That role takes time and training, and it competes with other priorities during a short inpatient stay or a crowded clinic visit.
Longitudinal tobacco support also needs workforce planning. In the screening-based cessation trial, fewer than four in ten patients assigned to an added medication-management service completed a visit.[7] Added service layers without protected staff time and outreach may not reach patients. Human infrastructure should be budgeted, measured and reviewed as part of the lung health pathway, not treated as background capacity. Rehabilitation capacity deserves the same scrutiny. Only 1.5% of Medicare patients began pulmonary rehabilitation within 90 days of a COPD admission, and more sessions were associated with lower risk of death.[14] Program slots and therapist hours are therefore part of the mortality conversation. Executives reviewing workforce plans for Healthy Lung Month can ask a simple question of each role in the pathway: if referrals doubled next quarter, who would absorb the work, and what would be dropped?
Executive guidance · Operating dashboard
Review reliability, not campaign activity alone.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Entry-point clarity
Can people and staff identify the approved first step without searching across conflicting instructions?
- Candidate local measure
- Locally defined contact, routing, and repeat-contact signals by channel and service.
Executive guidance · Signal
Ownership reliability
Does a specific team accept each request and make its status visible?
- Candidate local measure
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
Executive guidance · Signal
Partner-route reliability
Do participating teams share one current route and understand who owns each dependency?
- Candidate local measure
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Executive guidance · Signal
Improvement closure
Does the organization correct recurring friction and report what changed?
- Candidate local measure
- Selected barriers, assigned actions, completion status, and post-change review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Entry-point clarity | Executive sponsor and operational lead |
| Ownership reliability | Operational owner and participating teams |
| Partner-route reliability | Sending and receiving owners |
| Improvement closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Transfer responsibility with acknowledgment and visibility.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Name the sending and receiving owners, shared information, current status, and unresolved dependency.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Connect operating signals to accountable executive review.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Entry-point clarity | Can people and staff identify the approved first step without searching across conflicting instructions? | Executive sponsor and operational lead | At campaign launch and close |
| Ownership reliability | Does a specific team accept each request and make its status visible? | Operational owner and participating teams | At a locally defined cadence |
| Partner-route reliability | Do participating teams share one current route and understand who owns each dependency? | Sending and receiving owners | At a locally defined cadence |
| Improvement closure | Does the organization correct recurring friction and report what changed? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable lung health pathway
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Spirometry confirmation of COPD diagnoses in primary care | Undiagnosed patients go untreated and some diagnosed patients receive therapy without airflow obstruction | Primary care medical director with pulmonary function laboratory lead | Share of new COPD diagnoses with documented post-bronchodilator spirometry |
| Screening order placed after eligibility is identified | Eligible patients never begin screening even when navigation is available | Ambulatory quality lead and screening program director | Share of eligible patients with an order and completed first scan |
| Annual screening return and result follow-up tracked | Patients drop out after the first scan, with wider gaps for Black patients | Screening program director | Adherence to follow-up by result category, stratified by race and insurance |
| Default inpatient tobacco treatment referral matched to specialist capacity | Automatic referrals create queues and missed bedside consults | Chief nursing officer and tobacco treatment program lead | Consult delivery rate by hospital and referrals per specialist |
| Pulmonary rehabilitation referral at COPD discharge | Few patients start rehabilitation in the window associated with lower mortality | Hospital medicine lead and rehabilitation program manager | Share of COPD discharges referred and starting rehabilitation within 90 days |
| Balanced post-discharge outcome review | Readmission reductions mask rising post-discharge mortality | Chief medical officer and board quality committee | Readmission and 30-day post-discharge mortality reviewed together |
| Air quality event response plan | Children and patients with lung disease present in surges without guidance | Emergency management lead with pediatric and pulmonary leaders | Documented activation and communication during smoke events |
Control points derived from the cited evidence [2], [3], [4], [5], [6], [10], [11], [14] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Communicating lung health in ways that build informed participation
Lung cancer screening involves real trade-offs, which makes clear, balanced communication a quality requirement rather than a marketing choice. In a randomized trial among 516 tobacco quitline clients, a video decision aid left 67.4% of participants well prepared for a screening decision, compared with 48.2% of those who received standard educational material.[15] Participants who used the decision aid were also more likely to feel informed (50.0% versus 28.3%) and clear about their values.[15]
The same trial found that screening intentions and behavior did not differ between groups.[15] That result is useful for executives: better communication improved the quality of decisions without functioning as a promotional tool. Public messages during Healthy Lung Month should aim for informed choice and a clear next step, not volume of screening alone. The trial population also matters for interpretation: 26.7% of participants identified as Black and 43.8% reported a high school education or less.[15] Materials tested with populations like these are better suited to community outreach than materials written only for clinicians.
Communication also matters inside the system. The evidence that many patients with COPD are undiagnosed, and that some diagnosed patients do not show airflow obstruction on testing, suggests that patients and clinicians may be working from inaccurate labels.[6] Messages that encourage people with persistent symptoms or long smoking histories to ask about breathing tests can support diagnosis, provided the organization has the testing capacity to respond.[6]
Tobacco treatment messages need to match what the organization actually offers. When a hospital refers patients by default and follows up after discharge, it can describe a concrete service rather than a general encouragement to quit.[5] When screening programs offer cessation support alongside imaging, communication can connect the two services for patients who are already engaged.[7]
Air quality communication should be specific and practical. Wildfire smoke has been associated with more respiratory symptoms, hospital visits and medication use among children and adolescents.[2] Health systems can coordinate with schools, pediatric practices and community partners on where families should seek care during smoke events. Trust grows when public messages lead to services that are available, understandable and followed through. Because studies in this area used different exposure measures and outcome definitions, communication should describe practical steps and where to seek care rather than precise risk estimates.[2]
Executive guidance · 90-day plan
Use 90 days to correct one visible operating barrier.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how Healthy Lung Month communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how Healthy Lung Month communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Pair recognition with a system people can trust.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Connect the message to one usable, measured, and sustained operating change.
Executive action kit · Month observance
Turn Healthy Lung Month into accountable action.
Move from recognition activity to a visible operating route with named owners and closed loops.
Leadership focus
Use this observance to examine trustworthy information, prevention access, and community connection. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, access, coordination, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review language, disability, transportation, digital access, geography, trust, and other barriers using protected feedback and locally appropriate data.
Five-minute briefing
Inspect the operating sequence
Listen with people using the pathway, frontline teams, operational leaders, and community partners. Find one a message, request, referral, or handoff that does not reach an accountable owner, then test the locally approved route from entry through acknowledged follow-through.
- Listen
- Clarify entry
- Coordinate the partner route
- Protect transitions
- Verify and learn
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined contact, routing, and repeat-contact signals by channel and service.
- Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
- Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Public Health and Community Partners
Staff communication template
During Healthy Lung Month, our organization will connect awareness with a practical review of the information, access, coordination, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
Healthy Lung Month is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Eigestad TR, Hatløy K, Markussen HØ. Facilitators and Barriers to Uptake and Complete Pulmonary Rehabilitation for Patients With COPD: A Mixed Method Systematic Review. Journal of Clinical Nursing. 2026:online ahead of print, September 30, 2026. https://doi.org/10.1111/jocn.70543
- 2.Walters MK, Ward TJ. Respiratory health outcomes of children and adolescents exposed to wildfire smoke: a systematic review. International Journal of Environmental Health Research. 2025;36(6):1487-1501. https://doi.org/10.1080/09603123.2025.2579084
- 3.Bandi P, Star J, Ashad-Bishop K, Kratzer T, Smith R, Jemal A. Lung Cancer Screening in the US, 2022. JAMA Internal Medicine. 2024;184(8):882. https://doi.org/10.1001/jamainternmed.2024.1655
- 4.Bhalla S, Natchimuthu V, Lee JL, et al. Effect of Patient Navigation on Completion of Lung Cancer Screening in Vulnerable Populations. Journal of the National Comprehensive Cancer Network. 2024;22(3):151-157. https://doi.org/10.6004/jnccn.2023.7094
- 5.Cummings KM, Talbot V, Roberson A, et al. Implementation of an “opt-out” tobacco treatment program in six hospitals in South Carolina. BMC Health Services Research. 2024;24(1):741. https://doi.org/10.1186/s12913-024-11205-7
- 6.Perret J, Yip SWS, Idrose NS, et al. Undiagnosed and ‘overdiagnosed’ COPD using postbronchodilator spirometry in primary healthcare settings: a systematic review and meta-analysis. BMJ Open Respiratory Research. 2023;10(1):e001478. https://doi.org/10.1136/bmjresp-2022-001478
- 7.Fu SS, Rothman AJ, Vock DM, et al. Optimizing Longitudinal Tobacco Cessation Treatment in Lung Cancer Screening: A Sequential, Multiple Assignment, Randomized Trial. JAMA Network Open. 2023;6(8):e2329903. https://doi.org/10.1001/jamanetworkopen.2023.29903
- 8.Park Y, Kim J, Kim S, Moon D, Jo H. Effects of Transitional Care after Hospital Discharge in Patients with Chronic Obstructive Pulmonary Disease: An Updated Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 2023;20(11):6053. https://doi.org/10.3390/ijerph20116053
- 9.Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. The Lancet Respiratory Medicine. 2022;10(5):447-458. https://doi.org/10.1016/S2213-2600(21)00511-7
- 10.Kunitomo Y, Bade B, Gunderson CG, et al. Racial Differences in Adherence to Lung Cancer Screening Follow-up: A Systematic Review and Meta-analysis. Chest. 2022;161(1):266-275. https://doi.org/10.1016/j.chest.2021.07.2172
- 11.Puebla Neira DA, Hsu ES, Kuo YF, Ottenbacher KJ, Sharma G. Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 2021;203(4):437-446. https://doi.org/10.1164/rccm.202002-0310OC
- 12.Lopez-Olivo MA, Maki KG, Choi NJ, et al. Patient Adherence to Screening for Lung Cancer in the US: A Systematic Review and Meta-analysis. JAMA Network Open. 2020;3(11):e2025102. https://doi.org/10.1001/jamanetworkopen.2020.25102
- 13.Lake M, Shusted CS, Juon HS, et al. Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up. BMC Cancer. 2020;20(1):561. https://doi.org/10.1186/s12885-020-06923-0
- 14.Lindenauer PK, Stefan MS, Pekow PS, et al. Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries. JAMA. 2020;323(18):1813. https://doi.org/10.1001/jama.2020.4437
- 15.Volk RJ, Lowenstein LM, Leal VB, et al. Effect of a Patient Decision Aid on Lung Cancer Screening Decision-Making by Persons Who Smoke: A Randomized Clinical Trial. JAMA Network Open. 2020;3(1):e1920362. https://doi.org/10.1001/jamanetworkopen.2019.20362
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| Global COPD burden and environmental and occupational risk factors | [9] | 2022 | Current evidence | Modeled 2019 estimates for adults aged 30 to 79; most cases in low- and middle-income countries; spirometric definition affects prevalence. |
| Underdiagnosis and overdiagnosis of COPD in primary care | [6] | 2023 | Current evidence | Heterogeneous studies of modest quality; few studies contributed to each estimate. |
| Lung cancer screening prevalence and variation by state, insurance and usual source of care | [3] | 2024 | Current evidence | Self-reported national survey data for 2022; up-to-date status, not completion of follow-up. |
| Adherence to repeat lung cancer screening and predictors | [12] | 2020 | Current evidence | Fifteen U.S. studies with varying follow-up periods of 12 to 36 months and adherence definitions. |
| Wildfire smoke and pediatric respiratory outcomes | [2] | 2025 | Current evidence | Five studies in the United States and Canada; vote counting without pooled effect estimates. |
| Pulmonary rehabilitation after COPD hospitalization and survival | [14] | 2020 | Continuum of care | Retrospective Medicare cohort from 2014; residual confounding possible. |
| Transitional care and COPD readmission | [8] | 2023 | Continuum of care | Interventions varied; some outcomes not statistically significant. |
| Readmission policy, readmissions and post-discharge mortality | [11] | 2021 | Continuum of care | Observational time-period comparison in fee-for-service Medicare; association, not causation. |
| Opt-out inpatient tobacco treatment reach, capacity and quit rates | [5] | 2024 | Access | Six hospitals in one state; six-week self-reported outcomes among patients reached by survey. |
| Longitudinal tobacco treatment within lung cancer screening | [7] | 2023 | Access | Mostly White participants; added service had low completion. |
| Barriers and facilitators to pulmonary rehabilitation uptake and completion | [1] | 2026 | Access | Mixed-method review of 28 studies; action statements not yet tested. |
| Racial differences in lung cancer screening follow-up | [10] [13] | 2022, 2020 | Equity and trust | Seven studies with varying Black patient representation; single-program data in the second study. |
| Patient navigation in safety-net lung cancer screening | [4] | 2024 | Human infrastructure | Single safety-net system; telephone navigation only. |
| Decision aid and informed screening decisions | [15] | 2020 | Public communication | Quitline clients; outcomes are decision quality, not screening uptake. |

About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.

